In a limited US-centric look, it seems like the resources are at about the same level, with funding for cancer at ~$5.6 billion for the NCI[0], and ~3.6 billion for COVID19[1] (in June, not sure if more funding has been approved since).
Not sure what metric you want to consider for cancer survival, but the rough trend in 5-year cancer survival seems to be in the ballpark of improving between 0.25-1% yearly (until 2013)[2].
Ah yes, you're right. I just couldn't believe the number is that low since it looks so big from the inside (AACR had like 100k attendees). Especially when you compare this number to tech acquisitions...
In a limited US-centric look, it seems like the resources are at about the same level, with funding for cancer at ~$5.6 billion for the NCI[0], and ~3.6 billion for COVID19[1] (in June, not sure if more funding has been approved since).
Not sure what metric you want to consider for cancer survival, but the rough trend in 5-year cancer survival seems to be in the ballpark of improving between 0.25-1% yearly (until 2013)[2].
[0]: https://www.cancer.gov/about-nci/budget/fact-book/data/resea...
[1]: https://www.sciencemag.org/news/2020/06/nih-grapples-researc...
[2]: https://ourworldindata.org/grapher/five-year-cancer-survival...